Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol

Chemotherapy

Volumn 49, Issue 3, 2003, Pages 138-145

  Colovic M ^a   Bogdanovic A ^a   Jankovic G ^a   Kraguljac, N ^a   Suvajdzic N ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Adult acute lymphoblastic leukaemia; Survival

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DEATH; FEMALE; FOLLOW UP; GENDER; HUMAN; IMMUNOLOGY; IRRADIATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PROSPECTIVE STUDY; REINFORCEMENT; SIDE EFFECT; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037971089     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070620     Document Type: Article

References (22)

1. Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, Varet B, Broustet A, Cahn JY, Rigal-Houguet F, Witz F, Michaux JL, Michallet M, Reiffers J, for the French Group on Therapy for Adult Acute Lymphoblastic Leukemia: Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as postremis-sion therapy. J Clin Oncol 1993;11:1990-2001.
2. Linker CA, Levitt LJ, O'Donnell M, Forman SJ, Ries CA: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy. A follow-up report. Blood 1991;78:2814-2822.
3. Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA: A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998;92:1556-1564.
4. Rivera GK, Pinkel D, Sunone YV, Hancock ML, Christ WM: Treatment of acute lymphoblastic leukemia: 30 years' experience at St Jude Children's Research Hospital. N Engl J Med 1993;329:1289-1295.
5. Hoelzer D: Treatment options in adult acute lymphoblastic leukemia. 6th Meet EHA, Educational book, 1999, pp 49-53.
6. Hoelzer D: Acute lymphoblastic leukemia: Progress in children, less in adults. N Engl J Med 1993;239:1343-1344.
7. Čolović M, Janković G, Andolina M: Treatment of acute lymphoblastic leukemia. Bilt Hematol 1995;23:146-152.
8. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Garlnick HR, Sultan C: The morphological classification of acute lymphoblastic leukaemia: Concordance among observers and clinical correlations. Br J Haematol 1981;47:533-561.
9. First MIC Cooperative Study Group: Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Report of the workshop held in Leuven, Belgium, April 22-23, 1985. Cancer Genet Cytogenet 1986;23:189-197.
10. Foon KA, Todd RF: Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
11. Secker-Walker LM: Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990;49:1-13.
12. Novak A, Kruškić M, Ludoški M, Jurkovski V: Rapid method for obtaining high-quality chromosome banding in the study of hemopoietic neoplasia. Cancer Genet Cytogenet 1994;74:109-114.
13. Acute Leukemia Group B: Criteria for Evaluating Acute Leukemia of the Acute Leukemia Group B. June 1974 Modification of the 1969 Criteria. New York, Cancer and Leukemia Group B, Scarsdale, 1974.
14. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-461.
15. Sidney S: Nonparametric Statistics for the Behavioral Sciences. New York, McGraw Hill, 1956.
16. Kleinbaum DG: Survival analysis; in Dietz D, Gail M, Krickeberg K, Singer B (eds): Statistics in the Health Sciences. New York, Springer, 1996.
17. Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Koch P, Greund M, Diedrich H, Rühl H, Maschmayer G, Lipp T, Noworusian MR, Burkert M, Gerecke D, Pralle H, Müller U, Lunschken C, Fülle H, Ho AD, Busch FW, Schneider W, Görg C, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988;71:123-131.
18. Fiere D, Degos L, Reiffers L, Harousseau JL, Vernant JP, Michallet M, Sebban C, Lepage E: Allogeneic, autologous bone marrow transplantation and chemotherapy in first remission of adult acute lymphoblastic leukemia. Prospective study LALA87. Long-term results. Eur J Cancer 1999;35(suppl 4):331-332.
19. Finnish Leukaemia Group: Long-term survival in acute lymphoblastic leukaemia in adults: A prospective study of 51 patients. Eur J Haematol 1992;48:75-82.
20. Clarkson B, Gaynor J, Little C, Berman E, Kempin S, Andreeff M, Gulati S, Cunningham I, Gee T: Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Haematol Bluttransfus 1990;33:397-408.
21. Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, Azar C, Garl S, Benson L: Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: A non-antracycline containing regimen. Leukemia 1993;7:1236-1241.
22. Annino L, Ferrari A, Cedrone M, Giona F, Lo Coco F, Meloni G, Arcese W, Mandelli F: Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: Experience of treatments during a ten-year period. Leukemia 1994;8:664-667.